Skip to Main Content

New Paths in Predictive Payer Coverage


By Deborah Stoll, A MM&M Digital Publication; Drew Gutschmidt, President, Policy Reporter, a Mercalis company; Scott Dulitz, Chief Strategy Officer, Mercalis

Before going to market with a new drug, medical device, or test, it’s crucial to know how payers will treat it post-approval. Understanding post-launch coverage restrictions and knowing which payers are likely to publish policy in the first six months to two years allows organizations to design effective marketing strategies. Enter Bumblebee, a patented software system that tracks public domain payer policies that are either new or new versions of existing documents.

New Paths in Predictive Payer Coverage

Please submit the form below to view this resource.

Maximize value across the product and patient journeys. Find out how.